Kevesy (levetiracetam) 5 mg/ml Stragen solution for infusion

Pharmaceutical Form
Solution for infusion 5 mg / ml (clear, colorless to light yellow solution)

Indications
Kevesy is indicated as monotherapy in partial seizures with or without secondary generalization in adults and adolescents from 16 years of newly diagnosed epilepsy.

Kevesy is indicated as supplementary treatment:

  • In case of partial seizures with or without secondary generalization in adults, adolescents and children from four years of epilepsy.
  • In myoclonic seizures in adults and adolescents from 12 years of juvenile myoclonal epilepsy.
  • In primary generalized tonic-clonic seizures in adults and adolescents from 12 years of idiopathic generalized epilepsy.

Pack Sizes
10 x 100 ml


info@frostpharma.com

kevesy_product_popup

For more information

Kevesy (levetiracetam) 10 mg/ml Stragen solution for infusion

Pharmaceutical Form
Solution for infusion 10 mg / ml (clear, colorless to light yellow solution)

Indications
Kevesy is indicated as monotherapy in partial seizures with or without secondary generalization in adults and adolescents from 16 years of newly diagnosed epilepsy.

Kevesy is indicated as supplementary treatment:

  • In case of partial seizures with or without secondary generalization in adults, adolescents and children from four years of epilepsy.
  • In myoclonic seizures in adults and adolescents from 12 years of juvenile myoclonal epilepsy.
  • In primary generalized tonic-clonic seizures in adults and adolescents from 12 years of idiopathic generalized epilepsy.

Pack Sizes
10 x 100 ml

info@frostpharma.com

kevesy_product_popup

For more information

Kevesy (levetiracetam) 15 mg/ml Stragen solution for infusion

Pharmaceutical Form
Solution for infusion 15 mg / ml (clear, colorless to light yellow solution)

Indications
Kevesy is indicated as monotherapy in partial seizures with or without secondary generalization in adults and adolescents from 16 years of newly diagnosed epilepsy.

Kevesy is indicated as supplementary treatment:

  • In case of partial seizures with or without secondary generalization in adults, adolescents and children from four years of epilepsy.
  • In myoclonic seizures in adults and adolescents from 12 years of juvenile myoclonal epilepsy.
  • In primary generalized tonic-clonic seizures in adults and adolescents from 12 years of idiopathic generalized epilepsy.

Pack Sizes
10 x 100 ml


info@frostpharma.com

kevesy_product_popup

For more information

EnglishSwedish